HRTX · Company research
Heron Therapeutics, Inc. (HRTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Heron Therapeutics Expands U.S. Portfolio Through Licensing Deal - The Globe and Mail | Heron Therapeutics Expands U.S. Portfolio Through Licensing Deal The Globe and Mail | View source ↗ | The Globe and Mail | Sep 30, 2026 | neutral | 0 | 0.6 |
| Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Has Consensus Target Price of $2.00 - MarketBeat | Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Has Consensus Target Price of $2.00 MarketBeat | View source ↗ | MarketBeat | Sep 25, 2026 | neutral | 0 | 0.6 |
| Heron Therapeutics Stock Short Interest Rises to 31.36% - Quiver Quantitative | Heron Therapeutics Stock Short Interest Rises to 31.36% Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 26, 2026 | neutral | 0 | 0.6 |
| Heron Therapeutics (NasdaqCM:HRTX) Stock Forecast & Analyst Predictions - Simply Wall Street | Heron Therapeutics (NasdaqCM:HRTX) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Aug 11, 2026 | neutral | 0 | 0.6 |
| Heron Therapeutics Q2 Revenue Rises To $37.7 Million - Quiver Quantitative | Heron Therapeutics Q2 Revenue Rises To $37.7 Million Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 10, 2026 | neutral | 0 | 0.6 |
| HERON THERAPEUTICS Q2 2026 Earnings Preview: Recent $HRTX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative | HERON THERAPEUTICS Q2 2026 Earnings Preview: Recent $HRTX Insider Trading, Hedge Fund Activity, and More Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 7, 2026 | neutral | 0 | 0.6 |
| HERON THERAPEUTICS Q2 2026 Earnings Preview: Recent $HRTX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative | HERON THERAPEUTICS Q2 2026 Earnings Preview: Recent $HRTX Insider Trading, Hedge Fund Activity, and More Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 7, 2026 | neutral | 0 | 0.6 |
| Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision - Yahoo Finance | Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision Yahoo Finance | View source ↗ | Yahoo Finance | Jul 11, 2026 | neutral | 0 | 0.6 |
| Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent Court Ruling? - Yahoo Finance | Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent Court Ruling? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision - Yahoo Finance | Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision Yahoo Finance | View source ↗ | Yahoo Finance | Jun 27, 2026 | neutral | 0 | 0.6 |
| HRTX Forecast — Price Target — Prediction for 2027 - TradingView | HRTX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? - Stocktwits | Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? Stocktwits | View source ↗ | Stocktwits | Jun 2, 2026 | neutral | 0 | 0.6 |
| HRTX Edges Higher As Insider Ownership Change Draws Attention - StocksToTrade | HRTX Edges Higher As Insider Ownership Change Draws Attention StocksToTrade | View source ↗ | StocksToTrade | Apr 26, 2026 | neutral | 0 | 0.6 |
| Heron: Near The Bottom Of A Trading Range Despite Positives (NASDAQ:HRTX) - Seeking Alpha | Heron: Near The Bottom Of A Trading Range Despite Positives (NASDAQ:HRTX) Seeking Alpha | View source ↗ | Seeking Alpha | Feb 18, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.